Skip to main content
Back to Shenzhen Capital Group

Shenzhen Capital Group's Therapeutics Portfolio

Browse 3 Therapeutics companies funded by Shenzhen Capital Group. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
3
Total Funding in Therapeutics
$175.1M

Therapeutics Portfolio Companies (3)

Export
BiopharmaHealth CareMedicalTherapeutics

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Woburn, United States
December 2025
$110.0M
Series B

Founder Contacts

19,000+ verified contacts

MedicalMedical DeviceTherapeutics

Better Micro Medical is a medical device company that offers comprehensive solutions for peripheral vascular and structural heart disease.

Shenzhen, China
March 2026
$14.5M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Regend Therapeutics focuses on the human organ regenerative medicine business

Suzhou, China
February 2026
$50.6M
Series C

Founder Contacts

19,000+ verified contacts

Explore Shenzhen Capital Group's Full Portfolio

View all companies funded by Shenzhen Capital Group across every industry and funding stage.

View Full Shenzhen Capital Group Portfolio